The impacts of air pollution on public health have become a great concern worldwide. Ambient particulate matter (PM) is a major air pollution that comprises a heterogeneous mixture of different particle sizes and chemical components. The chemical composition and physicochemical properties of PM change with space and time, which may cause different impairments. However, the mechanisms of the adverse effects of PM on various systems have not been fully elucidated and systematically integrated. The Adverse Outcome Pathway (AOP) framework was used to comprehensively illustrate the molecular mechanism of adverse effects of PM and its components, so as to clarify the causal mechanistic relationships of PM-triggered toxicity on various systems. The main conclusions and new insights of the correlation between public health and PM were discussed, especially at low concentrations, which points out the direction for further research in the future. With the deepening of the study on its toxicity mechanism, it was found that PM can still induce adverse health effects with low-dose exposure. And the recommended Air Quality Guideline level of PM2.5 was adjusted to 5 μg/m3 by World Health Organization, which meant that deeper and more complex mechanisms needed to be explored. Traditionally, oxidative stress, inflammation, autophagy and apoptosis were considered the main mechanisms of harmful effects of PM. However, recent studies have identified several emerging mechanisms involved in the toxicity of PM, including pyroptosis, ferroptosis and epigenetic modifications. This review summarized the comprehensive evidence on the health effects of PM and the chemical components of it, as well as the combined toxicity of PM with other air pollutants. Based on the AOP Wiki and the mechanisms of PM-induced toxicity at different levels, we first constructed the PM-related AOP frameworks on various systems.
Graphical Abstract
Simulations of 108 emission reduction scenarios for NOx and VOCs using Comprehensive Air Quality Model with Extensions (CAMx) were conducted for eight cities in the Chengdu metropolitan area (CMA). The isopleth diagrams were drawn to explore the responses and differences of ozone (O3) concentrations to NOx and VOCs emission changes under Chengdu, CMA and Sichuan Province emission reduction scenarios. The results show that the O3-sensitive regimes of eight cities may change under different emission reduction scenarios. Under Chengdu emission reduction scenario, the Chengdu city is in the transition regime and O3 formation will shift from transition to VOC-limited when the VOCs emissions decreased by 50%, and the decreases in O3 concentrations caused by VOCs emission reductions are small. For the CMA and Sichuan Province emission reduction scenarios, all cities are NOx-limited in the baseline cases and with at least a 66% and a 77% reduction in NOx emissions, respectively, the daily maximum 8-h average O3 (MDA8) can attain the O3 standard (160 μg m−3). Although reductions in VOCs emissions can also lessen the O3 concentration, the effectiveness is relatively small. The changes in O3 concentrations under different VOCs to NOx emission reduction ratios indicate that all cities achieve a relatively high O3 concentration decrement with low VOCs to NOx emission reduction ratios and that the decreasing O3 concentrations caused by non-local emission reductions are much higher than those achieved by local emission reductions. In addition, the decreases in O3 concentrations in Chengdu are quite close when the total NOx and VOCs emissions reduction percentages are less than 30% under the CMA and Sichuan emission reduction scenarios.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.